Kanabo Group (LON:KNB) Stock Price Down 3.4% – Here’s Why

Kanabo Group Plc (LON:KNB) traded down 3.4% during trading on Monday . The company traded as low as GBX 0.70 ($0.01) and last traded at GBX 0.72 ($0.01). 101,200 shares changed hands during mid-day trading, a decline of 68% from the average session volume of 314,998 shares. The stock had previously closed at GBX 0.74 ($0.01).

Kanabo Group Stock Performance

The company has a quick ratio of 24.36, a current ratio of 2.78 and a debt-to-equity ratio of 3.48. The firm has a 50-day moving average of GBX 0.87 and a 200 day moving average of GBX 1.02. The stock has a market capitalization of £5.28 million, a P/E ratio of -0.65 and a beta of 3.04.

Kanabo Group Company Profile

Kanabo is creating a new standard in the medical cannabis industry by improving the well-being of millions around the world. Its focus is on the distribution of Cannabis-derived products for medical patients, and non-THC products for CBD consumers.

Kanabo have conducted extensive R&D in order to develop high-quality Cannabis extract formulas, innovative medical-grade vaporisers, and various non-smoking consumption solutions – making use easy and accessible for anyone in need of treatment.